Teleflex Inc (TFX)
217.64
-0.93
(-0.43%)
USD |
NYSE |
May 17, 16:00
217.57
-0.07
(-0.03%)
Pre-Market: 20:00
Teleflex Research and Development Expense (Quarterly): 37.30M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 37.30M |
| December 31, 2023 | 35.86M |
| September 30, 2023 | 37.58M |
| June 30, 2023 | 39.45M |
| March 31, 2023 | 41.47M |
| December 31, 2022 | 42.76M |
| September 30, 2022 | 37.77M |
| June 30, 2022 | 36.93M |
| March 31, 2022 | 36.36M |
| December 31, 2021 | 35.80M |
| September 30, 2021 | 31.82M |
| June 30, 2021 | 33.28M |
| March 31, 2021 | 29.95M |
| December 31, 2020 | 33.77M |
| September 30, 2020 | 29.22M |
| June 30, 2020 | 29.36M |
| March 31, 2020 | 27.40M |
| December 31, 2019 | 31.13M |
| September 30, 2019 | 27.98M |
| June 30, 2019 | 27.60M |
| March 31, 2019 | 27.15M |
| December 31, 2018 | 27.80M |
| September 30, 2018 | 26.36M |
| June 30, 2018 | 26.02M |
| March 31, 2018 | 26.03M |
| Date | Value |
|---|---|
| December 31, 2017 | 25.47M |
| September 30, 2017 | 21.19M |
| June 30, 2017 | 20.28M |
| March 31, 2017 | 17.83M |
| December 31, 2016 | 15.69M |
| September 30, 2016 | 15.07M |
| June 30, 2016 | 15.47M |
| March 31, 2016 | 12.35M |
| December 31, 2015 | 13.22M |
| September 30, 2015 | 12.57M |
| June 30, 2015 | 13.44M |
| March 31, 2015 | 12.88M |
| December 31, 2014 | 17.24M |
| September 30, 2014 | 14.87M |
| June 30, 2014 | 14.87M |
| March 31, 2014 | 14.06M |
| December 31, 2013 | 17.88M |
| September 30, 2013 | 15.64M |
| June 30, 2013 | 16.52M |
| March 31, 2013 | 15.01M |
| December 31, 2012 | 16.26M |
| September 30, 2012 | 14.76M |
| June 30, 2012 | 13.70M |
| March 31, 2012 | 11.55M |
| December 31, 2011 | 12.91M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
27.40M
Minimum
Mar 2020
42.76M
Maximum
Dec 2022
34.14M
Average
34.78M
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 368.00M |
| ResMed Inc | 77.07M |
| Boston Scientific Corp | 366.00M |
| Masimo Corp | 47.80M |
| NeuroMetrix Inc | 0.7324M |